138 related articles for article (PubMed ID: 23799931)
1. Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical use.
Montalban C; Abraira V; Arcaini L; Domingo-Domenech E; Guisado-Vasco P; Iannitto E; Mollejo M; Matutes E; Ferreri AJ; Salar A; Rattotti S; Carpaneto A; Perez R; Bello JL; Hernandez M; Caballero D; Carbonell F; Piris MA;
Leuk Lymphoma; 2014 Apr; 55(4):929-31. PubMed ID: 23799931
[No Abstract] [Full Text] [Related]
2. Management of marginal zone lymphoma.
Reid R; Friedberg JW
Oncology (Williston Park); 2013 Sep; 27(9):840, 842, 844. PubMed ID: 24282977
[No Abstract] [Full Text] [Related]
3. Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era.
Starr AG; Caimi PF; Fu P; Massoud MR; Meyerson H; Hsi ED; Mansur DB; Cherian S; Cooper BW; De Lima MJG; Lazarus HM; Gerson SL; Jagadeesh D; Smith MR; Dean RM; Pohlman BL; Hill BT; William BM
Hematology; 2017 Aug; 22(7):405-411. PubMed ID: 28105889
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.
Lenglet J; Traullé C; Mounier N; Benet C; Munoz-Bongrand N; Amorin S; Noguera ME; Traverse-Glehen A; Ffrench M; Baseggio L; Felman P; Callet-Bauchu E; Brice P; Berger F; Salles G; Brière J; Coiffier B; Thieblemont C
Leuk Lymphoma; 2014 Aug; 55(8):1854-60. PubMed ID: 24206091
[TBL] [Abstract][Full Text] [Related]
5. Peri-operative complications and hematologic improvement after first-line splenectomy for splenic marginal zone lymphoma.
Pata G; Damiani E; Bartoli M; Solari S; Anastasia A; Pagani C; Tucci A; Ragni F
Leuk Lymphoma; 2016; 57(6):1467-70. PubMed ID: 26373930
[No Abstract] [Full Text] [Related]
6. DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features.
Arribas AJ; Rinaldi A; Mensah AA; Kwee I; Cascione L; Robles EF; Martinez-Climent JA; Oscier D; Arcaini L; Baldini L; Marasca R; Thieblemont C; Briere J; Forconi F; Zamò A; Bonifacio M; Mollejo M; Facchetti F; Dirnhofer S; Ponzoni M; Bhagat G; Piris MA; Gaidano G; Zucca E; Rossi D; Bertoni F
Blood; 2015 Mar; 125(12):1922-31. PubMed ID: 25612624
[TBL] [Abstract][Full Text] [Related]
7. Splenic marginal zone lymphoma leads to sinistral portal hypertension.
Lv XH; Ma LL; Fu WY; Xie Y
J Dig Dis; 2019 Jan; 20(1):45-48. PubMed ID: 30549195
[No Abstract] [Full Text] [Related]
8. Clinical and diagnostic relevance of
Campos-Martín Y; Martínez N; Martínez-López A; Cereceda L; Casado F; Algara P; Oscier D; Menarguez FJ; García JF; Piris MA; Mollejo M
Haematologica; 2017 Aug; 102(8):e310-e312. PubMed ID: 28522570
[No Abstract] [Full Text] [Related]
9. Hyperviscosity syndrome in splenic marginal zone lymphoma.
Daniel R; Chan RY
Blood; 2018 Oct; 132(15):1627. PubMed ID: 30309878
[No Abstract] [Full Text] [Related]
10. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
Perrone S; D'Elia GM; Annechini G; Ferretti A; Tosti ME; Foà R; Pulsoni A
Leuk Res; 2016 May; 44():53-60. PubMed ID: 27030961
[TBL] [Abstract][Full Text] [Related]
11. Splenic marginal zone lymphoma masquerading as cirrhotic hypersplenism for seven years.
Carr JA
Can J Gastroenterol; 2012 Mar; 26(3):123-4. PubMed ID: 22462122
[No Abstract] [Full Text] [Related]
12. A peculiar case of splenic marginal zone lymphoma and review of literature.
Mishra MN; Pandey R; Dinda A; Nityanand S
Iran J Immunol; 2013 Sep; 10(3):186-9. PubMed ID: 24076596
[No Abstract] [Full Text] [Related]
13. Bone marrow-derived mesenchymal stem/stromal cells from patients with splenic marginal zone lymphoma are intrinsically impaired and influence the malignant B-cells.
Pontikoglou C; Kalyva A; Kalpadakis C; Velegraki M; Bizymi N; Alpantaki K; Kontakis G; Pangalis GA; Papadaki HA
Leuk Lymphoma; 2019 Feb; 60(2):538-540. PubMed ID: 29966468
[No Abstract] [Full Text] [Related]
14. Non-gastric marginal zone B-cell lymphoma in Korea: clinical features, treatment, and prognostic factors.
Oh SY; Suh C
Korean J Intern Med; 2010 Sep; 25(3):227-36. PubMed ID: 20830217
[TBL] [Abstract][Full Text] [Related]
15. [Splenic marginal zone lymphoma].
Dimopoulos K; Pedersen M
Ugeskr Laeger; 2012 Oct; 174(40):2383-6. PubMed ID: 23031300
[TBL] [Abstract][Full Text] [Related]
16. Splenic marginal zone lymphoma: current knowledge and future directions.
Thieblemont C; Davi F; Noguera ME; Brière J; Bertoni F; Zucca E; Traverse-Glehen A; Felman P; Berger F; Salles G; Coiffier B
Oncology (Williston Park); 2012 Feb; 26(2):194-202. PubMed ID: 22489356
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?
Ponzoni M; Kanellis G; Pouliou E; Baliakas P; Scarfò L; Ferreri AJ; Doglioni C; Bikos V; Dagklis A; Anagnostopoulos A; Ghia P; Stamatopoulos K; Papadaki T
Am J Surg Pathol; 2012 Nov; 36(11):1609-18. PubMed ID: 23073320
[TBL] [Abstract][Full Text] [Related]
18. Rituximab in a patient with splenic marginal zone lymphoma and acquired angioedema.
Motosue MS; Howard MT; Butterfield JH
Ann Allergy Asthma Immunol; 2016 May; 116(5):472-3. PubMed ID: 27017557
[No Abstract] [Full Text] [Related]
19. [Splenic marginal zone lymphoma].
Mohamed S
Pan Afr Med J; 2017; 26():111. PubMed ID: 28533834
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathogenesis of splenic and nodal marginal zone lymphoma.
Spina V; Rossi D
Best Pract Res Clin Haematol; 2017; 30(1-2):5-12. PubMed ID: 28288716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
